Scandinavian ChemoTech
1.43
SEK
+2.88 %
CMOTEC B
First North Stockholm
Biotechnology & Pharmaceuticals
Health Care
Be the first to follow this company
+2.88%
-18.29%
-34.4%
-20.56%
-44.88%
-33.86%
-91.09%
-80.31%
-96.2%
Scandinavian ChemoTech is a research and development company that has developed the technology Tumor-Specific Electroporation - TSE ™ for the treatment of various cancers. The technology means that electronic pulses are sent to the treated area and the membranes of the tumor cells are opened to reach their DNA. In addition to its operations in Sweden, the company is also active in Southeast Asia and India. Scandinavian ChemoTech was founded in 2015 and is headquartered in Lund.
Read moreMarket cap
33.38M SEK
Turnover
42.31K SEK
Revenue
2.82M
EBIT %
-717.73 %
P/E
-
Dividend yield-%
-
Financial calendar
4/3
2025
Annual report '24
ShowingAll content types
Scandinavian ChemoTech's Animal Care division is heading for a strong fourth quarter 2024 in terms of sales
ChemoTech's Animal Care Enters Strategic Collaboration with Norwegian Veterinary University's Hospital for Equine Medicine
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools